≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Simple and mucopurulent chronic bronchitis

DOID EFO Endpoint Browser PheWeb

J10_SIMPLBRONCH

bronchitis: An acute or chronic inflammatory process affecting the bronchi. [database_cross_reference: NCIT:C2911]

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — J41
  • Hospital discharge: ICD-9 — 491[0-1]
  • Hospital discharge: ICD-8 — 4910[1-2]
  • Cause of death: ICD-10 — J41
  • Cause of death: ICD-9 — 491[0-1]
  • Cause of death: ICD-8 — 4910[1-2]

2 out of 7 registries used, show all original rules.

1762

4. Check minimum number of events

None

1762

5. Include endpoints

None

1762

6. Filter based on genotype QC (FinnGen only)

1762

Control definitions (FinnGen only)

Control exclude
J10_LOWCHRON

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
J40-J47
Name in latin
Bronchitis chronica simplex sive mucopurulenta

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 19612 7277 11777
Only index persons 9480 4605 4875
Unadjusted period prevalence (%)
Whole population 0.29 0.21 0.33
Only index persons 0.18 0.17 0.19
Median age at first event (years)
Whole population 59.51 57.01 60.88
Only index persons 52.89 52.77 53.00

-FinnGen-

Key figures

All Female Male
Number of individuals 1762 681 1081
Unadjusted period prevalence (%) 0.38 0.23 0.48
Median age at first event (years) 54.66 49.83 57.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1623
Matched controls
16224
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
5612.2
323.0
431
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
323.0
617
*
J45.9
ICD-10 Finland
Asthma, unspecified
50.2
323.0
499
142
R03BB04
ATC
tiotropium bromide; inhalant
29.3
323.0
455
213
J41.0
ICD-10 Finland
Simple chronic bronchitis
1657.8
323.0
472
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
88.4
323.0
490
79
49101
ICD-8 Finland
Chronic bronchitis, Nonpurulenta (simplex)
+∞
315.1
292
*
R03AC02
ATC
salbutamol; inhalant
7.1
287.2
1079
3543
R03AK06
ATC
salmeterol and fluticasone; inhalant
16.3
250.9
428
348
J45.1
ICD-10 Finland
Nonallergic asthma
298.7
231.9
231
9
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
282.3
219.9
220
9
R03BA02
ATC
budesonide; inhalant
10.3
213.0
461
602
R03DA04
ATC
theophylline; systemic, rectal
19.7
205.7
322
201
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
15.5
195.7
338
271
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
88.5
195.2
216
28
H02AB06
ATC
prednisolone; systemic
4.8
189.0
981
3911
4910A
ICD-9 Finland
Chronic bronchitis, Simple chronic bronchitis
+∞
188.2
177
*
R03BA05
ATC
fluticasone; inhalant
8.4
184.3
453
716
UGC12
NOMESCO Finland
Flexible bronchoscopy
9.9
180.7
394
507
J45.0
ICD-10 Finland
Predominantly allergic asthma
87.2
173.9
193
25
R03BB01
ATC
ipratropium bromide; inhalant
17.6
172.5
281
191
R03AC12
ATC
salmeterol; inhalant
58.6
170.7
201
39
R03BA01
ATC
beclometasone; inhalant
9.6
160.7
356
463
R03AK07
ATC
formoterol and budesonide; inhalant
7.5
149.0
391
661
J47
ICD-10 Finland
Bronchiectasis
275.0
149.0
150
6
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
271.0
146.8
148
6
R03DC03
ATC
montelukast; oral
8.9
145.5
335
460
49102
ICD-8 Finland
Chronic bronchitis, Purulenta
+∞
133.2
126
*
J41.8
ICD-10 Finland
Mixed simple and mucopurulent chronic bronchitis
+∞
124.6
118
*
R03AC13
ATC
formoterol; inhalant
35.5
116.8
152
47
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
4.6
110.6
448
1235
4911A
ICD-9 Finland
Chronic bronchitis, Mucopurulent chronic bronchitis
+∞
106.4
101
*
J45
ICD-10 Finland
Asthma
16.3
106.1
176
120
R03AC03
ATC
terbutaline; inhalant
6.4
104.6
301
556
J42
ICD-10 Finland
Unspecified chronic bronchitis
98.2
100.4
110
12
49300
ICD-8 Finland
Asthma, bronchiale
+∞
95.8
91
*
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
+∞
93.6
89
*
J01AA02
ATC
doxycycline; systemic
3.3
93.4
1300
8860
J01FA06
ATC
roxithromycin; oral
3.0
90.3
764
3704
R96
ICPC
Asthma
13.5
86.0
154
125
R04.2
ICD-10 Finland
Haemoptysis
11.1
83.4
164
162
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
83.2
640
2868
R03AK08
ATC
formoterol and beclometasone; inhalant
45.2
82.8
102
24
J46
ICD-10 Finland
Status asthmaticus
147.4
79.8
84
6
H02AB04
ATC
methylprednisolone; systemic
4.3
77.2
320
870
J45.8
ICD-10 Finland
Mixed asthma
207.3
76.9
79
*
J01MA14
ATC
moxifloxacin; systemic
5.5
76.0
246
514
R03BA08
ATC
ciclesonide; inhalant
9.4
75.7
163
190
R05
ICD-10 Finland
Cough
3.5
72.2
405
1420
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
+∞
71.4
68
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
8.4
70.1
161
209
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
185.4
68.6
71
*
R95
ICPC
Chron obstructive pulmonary disease
41.6
66.4
83
21
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
8.1
65.8
155
209
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.2
63.3
264
712
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
62.6
780
4437
R06.0
ICD-10 Finland
Dyspnoea
2.9
61.0
467
2004
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.9
60.1
278
821
J96.1
ICD-10 Finland
Chronic respiratory failure
19.4
59.9
92
50
H02AB07
ATC
prednisone; oral
3.6
58.1
300
969
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
10.9
56.6
111
108
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
+∞
55.5
53
*
J01FA09
ATC
clarithromycin; systemic
2.7
55.2
484
2232
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
19.4
54.1
83
45
49099
ICD-8 Finland
Bronchitis, unspecified
+∞
52.4
50
*
XG474
NOMESCO Finland
Exhalation nntrogen oxide
20.2
52.3
79
41
J01FA10
ATC
azithromycin; systemic
2.2
49.6
789
4863
4912A
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]
+∞
49.2
47
*
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
62.0
46.6
54
9
J01MA12
ATC
levofloxacin; systemic
2.6
45.7
386
1712
J43.9
ICD-10 Finland
Emphysema, unspecified
236.4
45.2
46
*
49109
ICD-8 Finland
Chronic bronchitis, Unspecified
+∞
45.0
43
*
1240
FHL
Bronchoscopy
12.3
43.1
79
67
R06.2
ICD-10 Finland
Wheezing
8.1
42.3
98
128
51899
ICD-8 Finland
Bronchiectasis
+∞
40.8
39
*
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
60.4
40.4
47
8
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.8
40.4
142
318
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.6
39.5
105
168
R03AK11
ATC
formoterol and fluticasone; inhalant
26.5
39.1
54
21
R05CB01
ATC
acetylcysteine; inhalant, oral
11.2
39.1
75
70
J01FA15
ATC
telithromycin; oral
3.7
37.9
180
533
49104
ICD-8 Finland
Chronic bronchitis, Cum emphysemate
+∞
37.6
36
*
4940A
ICD-9 Finland
Bronchiectasis[BRONCHIECTASIAE]
+∞
37.6
36
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
36.7
703
4490
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
17.3
36.0
57
34
XG410
NOMESCO Finland
Flow-volume spirometry
6.2
35.9
100
170
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
+∞
35.5
34
*
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
28.4
34.7
47
17
R02
ICPC
Shortness of breath/dyspnoea
3.1
34.7
207
727
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.4
33.8
129
313
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.1
33.2
464
2582
TGC00
NOMESCO Finland
Bronchial lavation
7.6
33.2
79
108
R03DC01
ATC
zafirlukast; oral
21.9
32.3
47
22
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
9.5
32.3
67
73
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
9.5
32.3
67
73
J01DA01
ATC
[U] cefalexin; systemic
1.9
31.3
964
7150
R01AD08
ATC
fluticasone; nasal
2.2
31.0
380
1986
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.5
30.8
267
1174
R01AD09
ATC
mometasone; nasal
1.9
30.0
553
3407
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
5.3
29.9
94
186
J01CA04
ATC
amoxicillin; systemic
1.9
28.8
1134
9012
C03CA01
ATC
furosemide; systemic
1.9
28.6
614
3979
R05FB02
ATC
cough suppressants and expectorants
1.9
28.5
613
3979
R03BB02
ATC
oxitropium bromide; inhalant
26.6
28.4
39
15
N02AX02
ATC
tramadol; systemic, rectal
1.8
28.4
663
4424
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
28.2
500
3022
R06AE07
ATC
cetirizine; oral
1.9
28.0
552
3464
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.5
27.5
73
117
R05DA20
ATC
opium alkaloids and derivatives - combinations
2.1
27.1
385
2125
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
5.1
27.1
88
181
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
+∞
26.1
25
*
J31.0
ICD-10 Finland
Chronic rhinitis
3.5
25.2
123
371
A02BC01
ATC
omeprazole; systemic
1.9
25.1
468
2859
GD1AD
NOMESCO Finland
Thorax CT examination
4.5
25.1
92
215
4900A
ICD-9 Finland
Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]
+∞
25.1
24
*
A02BC03
ATC
lansoprazole; oral
1.9
24.8
470
2882
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.6
24.8
74
138
TDM10
NOMESCO Finland
Puncture of maxillary antrum
6.3
24.5
66
108
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
56.9
24.1
28
5
R05CB03
ATC
carbocisteine; oral
5.7
24.0
70
127
J20
ICD-10 Finland
Acute bronchitis
2.9
24.0
151
546
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
23.9
460
2831
A02BC02
ATC
pantoprazole; systemic
1.7
23.7
930
7145
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.0
23.5
97
254
R05FA02
ATC
opium derivatives and expectorants; systemic
1.8
23.0
574
3839
78310
ICD-8 Finland
Symptoms referable to respiratory system, Haemoptysis
23.3
22.6
32
14
A07AA02
ATC
nystatin; oral
3.2
22.5
123
404
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
22.5
321
1762
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
11.6
22.2
41
36
G47.3
ICD-10 Finland
Sleep apnoea
2.1
22.2
280
1462
R03AC18
ATC
indacaterol; inhalant
52.8
22.1
26
5
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.5
22.1
108
326
A02BC05
ATC
esomeprazole; systemic
1.7
21.6
566
3822
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.7
21.3
97
277
R05CB02
ATC
bromhexine; systemic
5.8
21.1
60
106
N03AX16
ATC
pregabalin; oral
1.9
20.9
336
1925
R01AD01
ATC
beclometasone; nasal
2.3
20.8
210
987
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
6.8
20.7
52
78
XQ800
NOMESCO Finland
Prick test
3.7
20.7
94
268
R01AD12
ATC
fluticasone furoate; nasal
2.0
20.5
317
1786
R03DA05
ATC
aminophylline; systemic, rectal
12.7
20.4
36
29
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.6
20.2
155
629
R29
ICPC
Respiratory symptom/complaint other
3.4
20.1
100
306
J01DA06
ATC
[U] cefuroxime; systemic
2.2
20.1
228
1129
UJF32
NOMESCO Finland
Coloscopy
1.8
20.1
409
2540
4919X
ICD-9 Finland
Chronic bronchitis, Unspecified chronic bronchitis
+∞
19.8
19
*
R03BC03
ATC
nedocromil; inhalant
3.1
19.5
110
368
J01FF01
ATC
clindamycin; systemic
1.8
18.9
378
2331
7863A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Haemoptysis
17.3
18.7
29
17
R03AC04
ATC
fenoterol; inhalant
101.2
18.6
20
*
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
192.0
18.6
19
*
R28
ICPC
Limited function/disability (R)
9.7
18.4
37
39
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
25.3
18.2
25
10
SPAT1058
SPAT
PEF monitoring instruction
3.0
18.1
106
366
N05CF01
ATC
zopiclone; oral
1.7
18.0
529
3653
Y0499
ICD-8 Finland
Investigation of respiratory system
7.0
17.5
43
63
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
7.3
17.3
41
57
A01AB09
ATC
miconazole; local oral
2.4
17.2
147
636
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
17.2
387
2465
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
17.1
146
631
R05
ICPC
Cough
1.9
16.9
277
1588
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.7
16.9
380
2417
XG460
NOMESCO Finland
Short time oxymetry
5.9
16.8
47
82
N06AA09
ATC
amitriptyline; systemic
2.3
16.8
163
752
J37.0
ICD-10 Finland
Chronic laryngitis
4.9
16.7
55
116
R81
ICPC
Pneumonia
3.9
16.6
69
183
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
16.6
241
1320
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
16.3
467
3182
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
5.9
16.2
45
78
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
16.2
358
2262
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
16.1
291
1720
N05BA01
ATC
diazepam; systemic, rectal
2.0
16.1
218
1160
G44.2
ICD-10 Finland
Tension-type headache
2.2
16.0
165
782
R50.9
ICD-10 Finland
Fever, unspecified
2.0
15.8
218
1168
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
+∞
15.6
15
*
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
7.5
15.5
36
49
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
15.3
116
470
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
15.2
457
3143
J02AC01
ATC
fluconazole; systemic
1.6
15.2
450
3083
R03BB07
ATC
umeclidinium bromide; inhalant
23.6
15.1
21
9
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
15.1
433
2943
P01AB01
ATC
metronidazole; oral, rectal
1.6
14.9
490
3444
J01FA01
ATC
erythromycin; systemic
2.1
14.9
170
840
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
2.0
14.9
201
1065
M54.5
ICD-10 Finland
Low back pain
1.7
14.9
385
2539
N03AX12
ATC
gabapentin; oral
2.0
14.8
206
1107
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
9.0
14.5
30
34
C01DA14
ATC
isosorbide mononitrate; oral
1.7
14.5
351
2271
SPAT1059
SPAT
Spirometry at the office
3.6
14.4
64
181
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
19.3
14.2
21
11
R05DB20
ATC
other cough suppressants - combinations
2.7
14.1
98
377
A03FA02
ATC
cisapride; oral, rectal
2.2
14.0
146
693
A02BA02
ATC
ranitidine; systemic
1.7
14.0
323
2055
M79.6
ICD-10 Finland
Pain in limb
1.6
14.0
433
2993
R06AX27
ATC
desloratadine; oral
1.8
13.9
274
1663
C07AB07
ATC
bisoprolol; oral
1.5
13.9
725
5662
R51.80
ICD-10 Finland
Headache
2.1
13.7
170
870
N06AX21
ATC
duloxetine; oral
2.3
13.7
132
606
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
16.3
13.5
21
13
N06AX11
ATC
mirtazapine; oral
1.6
13.4
407
2791
N07BA03
ATC
varenicline; oral
3.9
13.4
54
141
N05CD07
ATC
temazepam; oral
1.8
13.3
241
1419
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
21.3
13.3
19
9
A01AB04
ATC
amphotericin B; local oral
2.7
13.1
93
363
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
8.4
13.0
28
34
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
13.0
102
421
D07AC01
ATC
betamethasone; topical
1.6
12.9
452
3211
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.8
12.8
54
147
R03CC02
ATC
salbutamol; systemic
3.4
12.7
61
184
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
6.8
12.7
31
46
J01DA08
ATC
[U] cefaclor; oral
2.3
12.6
124
573
XG466
NOMESCO Finland
Sleep oxymetry
3.8
12.6
53
144
J32.4
ICD-10 Finland
Chronic pansinusitis
8.8
12.5
26
30
R03CC03
ATC
terbutaline; systemic
7.2
12.3
29
41
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
7.2
12.3
29
41
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
6.0
12.3
33
56
C08DB01
ATC
diltiazem; oral
2.2
12.2
126
597
R03DA54
ATC
theophylline, combinations excl. psycholeptics; systemic
5.3
12.1
36
69
XG405
NOMESCO Finland
Education on PEF monitoring
8.2
12.1
26
32
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
12.0
147
749
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
4.5
12.0
41
92
J01MA01
ATC
ofloxacin; systemic
2.0
11.9
165
882
R03BB06
ATC
glycopyrronium bromide; inhalant
47.0
11.9
14
*
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
47.0
11.9
14
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
11.8
218
1292
C01AA05
ATC
digoxin; systemic
1.8
11.8
204
1182
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.4
11.8
104
459
R01AD05
ATC
budesonide; nasal
2.4
11.7
98
420
R01AD11
ATC
triamcinolone; nasal
2.3
11.7
111
505
N05BA04
ATC
oxazepam; oral
1.6
11.7
337
2272
SPAT1057
SPAT
Peak expiratory flow measurement
5.8
11.6
32
56
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
12.6
11.6
20
16
348
Kela drug reimbursment
Roflumilast
+∞
11.5
11
*
48509
ICD-8 Finland
Bronchopneumonia, unspecified
7.5
11.4
26
35
R09.3
ICD-10 Finland
Abnormal sputum
7.9
11.4
25
32
R78
ICPC
Acute bronchitis/bronchiolitis
4.2
11.2
42
103
R07.3
ICD-10 Finland
Other chest pain
2.1
11.1
130
650
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
11.1
202
1193
N06AX16
ATC
venlafaxine; oral
2.0
11.1
141
733
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
5.0
11.0
34
69
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
10.9
223
1362
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
10.8
558
4280
A02BA03
ATC
famotidine; systemic
2.4
10.7
86
363
48609
ICD-8 Finland
Pneumonia, unspecified
5.2
10.6
32
63
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
5.2
10.6
32
63
SPAT1257
SPAT
Teaching of medicine inhalation technique
3.6
10.5
46
130
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
7.4
10.5
24
33
J01MA02
ATC
ciprofloxacin; systemic
1.4
10.4
573
4443
4939B
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]
+∞
10.4
10
*
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
+∞
10.4
10
*
R03DX07
ATC
roflumilast; oral
+∞
10.4
10
*
7862A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Cough
7.8
10.4
23
30
N06AA12
ATC
doxepin; systemic
2.4
10.4
86
368
J98.1
ICD-10 Finland
Pulmonary collapse
16.1
10.3
16
10
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
12.1
10.3
18
15
R06AX13
ATC
loratadine; oral
1.9
10.3
158
877
M48.0
ICD-10 Finland
Spinal stenosis
1.8
10.2
177
1026
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
10.1
136
721
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
11.4
10.1
18
16
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.0
10.1
137
730
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
9.2
10.0
20
22
C08DA01
ATC
verapamil; systemic
2.6
10.0
74
298
M04AA01
ATC
allopurinol; systemic
1.7
9.9
228
1443
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.5
9.9
77
320
R13
ICD-10 Finland
Dysphagia
2.2
9.8
98
457
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
4.8
9.8
31
65
UDC00
NOMESCO Finland
Ear microscopy
2.1
9.7
107
522
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
9.7
211
1311
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
9.6
210
1309
UDM02
NOMESCO Finland
Sinoscopy
4.3
9.6
34
80
J01DB01
ATC
cefalexin; oral
1.4
9.6
1061
9297
N06AB04
ATC
citalopram; systemic
1.6
9.5
282
1908
J41
ICD-10 Finland
Simple and mucopurulent chronic bronchitis
100.6
9.4
10
*
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
9.4
310
2146
R06.5
ICD-10 Finland
Mouth breathing
2.1
9.4
105
518
R03BB05
ATC
aclidinium bromide; inhalant
+∞
9.4
9
*
J01GB01
ATC
tobramycin; inhalant, parenteral
+∞
9.4
9
*
49309
ICD-8 Finland
Asthma, Unspecified
+∞
9.4
9
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
9.4
223
1421
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
9.4
132
714
R06AX22
ATC
ebastine; oral
1.8
9.3
170
1003
K30
ICD-10 Finland
Functional dyspepsia
2.0
9.3
125
663
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
9.3
144
804
R06AE09
ATC
levocetirizine; oral
1.9
9.2
143
798
R05DA01
ATC
ethylmorphine; oral
2.0
9.1
113
580
A07EC01
ATC
sulfasalazine; oral, rectal
2.1
9.1
105
526
L04AX01
ATC
azathioprine; systemic
2.7
8.9
57
213
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.1
8.8
99
490
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
8.8
428
3221
0
FHL
NA
14.1
8.7
14
10
R79
ICPC
Chronic bronchitis
50.2
8.7
10
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
8.7
222
1442
7860A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]
6.6
8.7
21
32
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
8.7
402
2996
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.6
8.7
37
104
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
8.6
180
1106
A06AD11
ATC
lactulose; oral
1.6
8.6
264
1796
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
8.6
80
363
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
8.6
324
2311
XF400
NOMESCO Finland
ECG with 12 standard connections
1.6
8.6
262
1780
N05AH04
ATC
quetiapine; oral
1.7
8.6
189
1180
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
8.5
138
781
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
7.0
8.5
20
29
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
8.5
129
715
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
20.1
8.5
12
6
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.8
8.4
146
847
B96.5
ICD-10 Finland
Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters
90.5
8.4
9
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
8.4
176
1082
XF402
NOMESCO Finland
ECG with work load test
1.8
8.4
154
909
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.3
8.3
78
355
R05DB05
ATC
pentoxyverine; oral, rectal
2.6
8.2
57
224
J86.9
ICD-10 Finland
Pyothorax without fistula
6.5
8.2
20
31
R06.4
ICD-10 Finland
Hyperventilation
5.2
8.2
24
47
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.8
8.2
131
739
WW200
NOMESCO Finland
Immunization
3.4
8.1
38
115
N05AF03
ATC
chlorprothixene; systemic
3.4
8.1
37
110
N05BA12
ATC
alprazolam; oral
1.9
8.1
125
696
R11
ICD-10 Finland
Nausea and vomiting
2.0
8.1
106
559
R74
ICPC
Upper respiratory infection acute
1.5
8.1
255
1747
SPAT1263
SPAT
Sampling
1.4
8.0
519
4100
N06AB06
ATC
sertraline; oral
1.9
8.0
113
609
1430
FHL
Laryngoscopy (direct)
22.1
8.0
11
5
WX723
NOMESCO Finland
CPAP therapy
2.9
8.0
46
160
A02BA04
ATC
nizatidine; systemic
1.8
8.0
126
708
D07AD01
ATC
clobetasol; topical
1.7
8.0
183
1156
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
3.2
7.9
39
123
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
3.2
7.9
39
123
UJD02
NOMESCO Finland
Gastroscopy
2.2
7.9
80
377
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.3
7.9
73
332
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
7.8
188
1202
M05BA04
ATC
alendronic acid; oral
1.9
7.7
119
665
120
Kela drug reimbursment
Hypogammaglobulinaemia
45.2
7.7
9
*
UGC02
NOMESCO Finland
Rigid bronchoscopy
15.1
7.7
12
8
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.1
7.7
79
378
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
18.4
7.6
11
6
R05CA10
ATC
expectorants - combinations
3.2
7.6
38
122
I50.0
ICD-10 Finland
Congestive heart failure
1.7
7.6
147
884
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.5
7.6
57
235
N02AC04
ATC
dextropropoxyphene; oral
2.1
7.6
83
409
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.3
7.5
65
286
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
10.1
7.5
14
14
SPAT1262
SPAT
Handing over of treatment supplies
1.5
7.5
250
1732
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.8
7.4
125
717
5861
FHL
Pleural biopsy or removal of local change
80.4
7.4
8
*
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
7.4
225
1526
N06AB10
ATC
escitalopram; oral
1.6
7.4
197
1294
N06AB03
ATC
fluoxetine; oral
1.7
7.3
140
839
WX722
NOMESCO Finland
PEEP
2.3
7.3
66
297
4939A
ICD-9 Finland
Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]
+∞
7.3
7
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
7.3
173
1103
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
7.2
270
1917
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.4
7.2
57
241
M03BX02
ATC
tizanidine; oral
1.3
7.2
671
5602
N05AA02
ATC
levomepromazine; systemic
2.3
7.2
65
293
J01DC02
ATC
cefuroxime; systemic
2.2
7.1
68
315
R03BA07
ATC
mometasone; inhalant
8.0
7.1
15
19
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
7.1
62
276
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.9
7.1
27
70
M47.82
ICD-10 Finland
Other spondylosis, cervical region
2.4
7.0
54
226
Z50.1
ICD-10 Finland
Other physical therapy
2.1
7.0
79
394
L03
ICPC
Low back symptom/complaint
1.5
7.0
247
1732
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.6
7.0
47
183
Y0599
ICD-8 Finland
Investigation of digestive system
3.3
7.0
33
102
E000001
ATC
NA
1.5
7.0
237
1646
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
6.9
131
780
N03AF01
ATC
carbamazepine; oral, rectal
2.0
6.9
82
414
A03CA02
ATC
clidinium and psycholeptics; oral
1.9
6.9
93
497
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
6.9
168
1080
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.0
6.9
78
391
WX780
NOMESCO Finland
Remote monitoring CPAP
2.6
6.8
46
180
Z01.9
ICD-10 Finland
Special examination, unspecified
2.1
6.8
73
358
4289X
ICD-9 Finland
Heart failure, unspecified
4.3
6.7
23
54
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.5
6.7
48
193
N03AE01
ATC
clonazepam; systemic
2.1
6.7
68
325
SPAT1260
SPAT
Consultation of another employee
1.5
6.7
213
1458
S80.0
ICD-10 Finland
Contusion of knee
2.1
6.7
70
339
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
6.7
117
683
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.1
6.7
74
366
30041
ICD-8 Finland
Neuroses, Depressiva
3.7
6.7
27
74
M79.7
ICD-10 Finland
Fibromyalgia
3.2
6.7
33
106
M01AH02
ATC
rofecoxib; oral
1.6
6.7
176
1152
ZXA10
NOMESCO Finland
Bilateral
1.5
6.6
240
1690
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
6.6
94
510
5188X
ICD-9 Finland
Other diseases of lung
7.8
6.6
14
18
N06AX03
ATC
mianserin; oral
2.2
6.6
66
312
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.9
6.6
94
513
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.9
6.5
88
472
R03BC01
ATC
cromoglicic acid; inhalant
6.9
6.5
15
22
A02BX02
ATC
sucralfate; oral
2.1
6.5
73
364
WX725
NOMESCO Finland
Noninvasive ventilation
2.3
6.5
55
240
C03DA01
ATC
spironolactone; oral
1.6
6.4
151
960
M01AB05
ATC
diclofenac; systemic, rectal
1.3
6.4
821
7133
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.1
6.4
66
318
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
70.1
6.4
7
*
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
70.1
6.4
7
*
XG431
NOMESCO Finland
Oscillometric spirometry with exercise provocation
70.1
6.4
7
*
N05BB01
ATC
hydroxyzine; systemic
2.0
6.4
79
409
79399
ICD-8 Finland
Observation, without need for further medical care, Unspecified
4.3
6.4
22
52
R01AD
ATC
Corticosteroids
4.7
6.4
20
43
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
2.6
6.4
43
168
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
6.3
344
2622
48601
ICD-8 Finland
More specifically, unspecified pneumonia and the pleural irritation caused by it
8.2
6.3
13
16
XJC10
NOMESCO Finland
Oesophageal pH monitoring
8.2
6.3
13
16
5301A
ICD-9 Finland
Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]
5.5
6.3
17
31
C01CA24
ATC
epinephrine; parenteral
2.3
6.3
55
247
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
6.3
62
294
XW1XT
NOMESCO Finland
Biopsy from other organ close to skin with other quidance
+∞
6.3
6
*
J01XB01
ATC
colistin; inhalant, parenteral
+∞
6.3
6
*
49308
ICD-8 Finland
Asthma, Alia definita
+∞
6.3
6
*
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.8
6.2
37
134
R03DB04
ATC
theophylline and adrenergics; systemic
26.8
6.2
8
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.2
6.2
30
95
UDQ22
NOMESCO Finland
Microlaryngoscopy
4.8
6.2
19
40
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.8
6.2
37
135
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.7
6.2
111
655
R01AX03
ATC
ipratropium bromide; nasal
2.6
6.2
41
159
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.5
6.2
44
177
I45.9
ICD-10 Finland
Conduction disorder, unspecified
5.4
6.2
17
32
A03
ICPC
Fever
1.6
6.1
146
932
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
6.1
317
2396
N06AX12
ATC
bupropion; oral
2.3
6.1
50
217
H02AB09
ATC
hydrocortisone; systemic
2.9
6.1
33
114
E66.00
ICD-10 Finland
Metabolic syndrome
2.1
6.1
61
292

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023419) Bacteria identified in Sputum by Culture
178
80
24.63
246.49
4.1
1.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
232
414
6.30
127.04
1.7
1.2
u/ml
177.3
196.4
0.11
220
371
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
78
25
32.59
120.50
1.5
1.1
u/ml
1.1
0.0
—
45
6
(3042631) Mycobacterium sp identified in Specimen
115
140
8.72
88.45
4.9
2.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
68
44
16.03
78.88
5.8
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
178
385
5.03
78.04
3.3
2.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
100
123
8.56
76.16
1.3
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
132
249
5.65
67.32
1.8
1.5
—
—
—
0
0
(4062490)
77
79
10.14
67.26
1.3
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
75
79
9.87
64.26
1.3
1.3
g/l
2.6
2.5
0.04
46
56
(3024139) IgG subclass 3 [Mass/volume] in Serum
75
79
9.87
64.26
1.3
1.3
g/l
0.4
0.5
0.72
47
56
(3027135) IgG subclass 1 [Mass/volume] in Serum
75
79
9.87
64.26
1.3
1.3
g/l
6.0
7.6
1.58
46
57
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
80
98
8.50
61.03
4.6
3.5
—
—
—
0
0
(4010399)
192
548
3.81
58.26
1.5
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
81
139
6.06
45.46
1.3
1.6
g/l
0.5
0.9
2.45
52
105
(3000494) Fungus identified in Specimen by Culture
298
1285
2.59
43.86
1.9
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
666
4039
2.04
42.90
7.8
6.1
—
—
—
0
0
(3000492) Spirometry study
198
713
3.00
41.02
1.9
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
216
828
2.83
39.89
3.3
3.0
g/l
10.3
10.8
0.72
201
757
(3022096) Basophils/100 leukocytes in Blood
799
5276
1.94
39.38
8.4
6.1
%
0.6
0.6
0.40
763
4866
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
96
223
4.49
38.24
3.4
3.7
%
55.4
58.7
1.46
96
223
(3019069) Monocytes/100 leukocytes in Blood
810
5452
1.90
36.94
8.7
6.3
%
8.8
8.9
0.44
773
5052
(3006504) Eosinophils/100 leukocytes in Blood
807
5432
1.90
36.74
8.4
6.1
%
2.8
2.8
0.14
767
5009
(3030905) Polymorphonuclear cells [#/volume] in Blood
91
211
4.49
36.32
3.2
3.2
e9/l
4.2
4.3
0.03
91
211
(3002030) Lymphocytes/100 leukocytes in Blood
818
5568
1.87
35.62
8.7
6.3
%
26.8
27.2
0.42
782
5129
(3013115) Eosinophils [#/volume] in Blood
856
5913
1.87
35.56
8.2
6.1
e9/l
0.2
0.2
1.38
776
5073
(3028026) IgM [Mass/volume] in Serum or Plasma
178
665
2.86
34.33
1.8
1.9
g/l
1.3
1.5
0.63
168
602
(3021440) Promyelocytes/100 leukocytes in Blood
217
902
2.60
34.00
4.3
4.5
%
0.1
0.1
0.07
55
289
(3018010) Neutrophils/100 leukocytes in Blood
801
5474
1.85
33.92
8.3
6.0
%
57.9
57.6
0.34
762
5064
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
80
178
4.66
33.60
1.6
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
826
5732
1.83
32.99
7.8
5.8
e9/l
0.6
0.6
3.22
746
4824
(3025159) Blasts/100 leukocytes in Blood
203
834
2.62
32.52
4.5
4.5
%
0.0
0.2
1.18
46
237
(3006315) Basophils [#/volume] in Blood
827
5759
1.82
32.49
7.9
5.8
e9/l
0.0
0.0
2.19
749
4852
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
69
140
5.09
32.31
1.7
1.5
—
—
—
0
0
(4015189)
29
20
14.72
32.25
4.3
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
51
78
6.70
31.99
1.5
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
91
233
4.06
31.90
3.0
3.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
221
957
2.50
31.70
4.4
4.4
%
0.7
0.9
0.43
58
314
(3002179) Metamyelocytes/100 leukocytes in Blood
204
851
2.58
31.65
4.3
4.2
%
0.8
0.6
0.26
46
218
(3019198) Lymphocytes [#/volume] in Blood
836
5876
1.80
31.54
8.0
5.9
e9/l
1.9
2.0
0.07
760
5045
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
389
2157
2.03
30.45
2.4
1.8
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
104
313
3.47
28.85
3.8
5.0
mmol/l
25.4
24.3
1.77
91
270
(3028626) Oxygen [Partial pressure] in Capillary blood
113
378
3.13
26.41
6.7
7.4
kpa
8.1
8.4
1.51
106
351
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
197
879
2.40
26.30
6.2
5.6
kpa
5.2
5.1
1.80
187
810
(3009343) pH of Capillary blood
195
867
2.40
26.23
6.2
5.6
ph
7.4
7.4
1.75
40
86
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
189
835
2.41
25.78
6.2
5.7
mmol/l
2.3
1.6
2.84
148
609
(1616796) Gas panel - Central venous blood
89
261
3.54
25.68
5.7
4.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
901
6750
1.68
24.92
10.7
9.2
e9/l
4.5
4.2
3.77
812
5812
(40760892) CBC W Ordered Manual Differential panel - Blood
393
2326
1.89
24.84
6.0
4.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
94
292
3.34
24.81
1.7
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
284
1514
2.04
24.31
2.2
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
211
1007
2.24
24.01
4.9
4.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
61
144
4.35
23.81
1.6
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
22
16
13.91
23.66
1.2
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
86
262
3.40
23.40
2.9
2.4
%
16.5
16.0
0.49
53
123
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
64
161
4.09
22.99
1.6
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
88
279
3.27
22.48
1.7
1.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
23
20
11.64
22.26
1.4
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
276
1514
1.98
21.64
2.3
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
75
221
3.50
21.50
1.8
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
58
144
4.13
21.21
1.8
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
549
3753
1.67
20.51
5.9
4.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
254
1384
1.98
20.23
2.3
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
164
778
2.22
18.82
4.2
4.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
71
221
3.30
18.70
1.4
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
296
1745
1.84
18.44
2.1
2.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
61
178
3.51
17.77
1.7
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
198
1040
2.02
17.39
4.0
4.0
mmol/l
1.2
1.2
0.00
173
890
(3011412) CD3 cells [#/volume] in Blood
46
112
4.19
17.29
1.8
2.6
e9/l
1.6
1.1
1.81
29
66
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
371
2381
1.71
17.13
2.1
1.9
mg/l
1.2
1.5
0.62
281
1847
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
74
4.94
16.65
1.9
1.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
79
283
2.87
16.40
7.3
4.5
mmol/l
3.4
2.6
1.15
59
177
(3037522) Nuclear Ab [Titer] in Serum
231
1305
1.89
16.35
1.5
1.3
titre
386.4
489.6
0.61
47
291
(3021589) Normoblasts [#/volume] in Blood
694
5242
1.53
16.11
15.3
10.0
e9/l
0.0
0.0
0.03
603
4227
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
239
1374
1.86
16.01
4.2
3.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
93
370
2.60
15.79
1.8
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
37
82
4.59
15.67
2.0
3.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
72
254
2.91
15.37
2.5
2.2
g/l
130.8
127.2
0.60
59
188
(40768797) Stomach Pathology biopsy report
260
1557
1.79
15.19
1.3
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
31
61
5.15
15.07
2.0
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
31
61
5.15
15.07
2.0
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
37
85
4.42
15.00
1.8
2.8
%
9.4
12.2
0.81
17
46
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
178
950
1.97
14.89
1.9
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
75
277
2.78
14.73
1.8
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
75
277
2.78
14.73
1.8
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
410
2810
1.60
14.33
3.5
2.7
e6/l
6.0
5.1
0.64
371
2482
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
524
3812
1.53
14.03
3.2
2.5
u/l
63.1
59.7
0.22
474
3503
(3014133) Dog dander IgE Ab [Units/volume] in Serum
33
74
4.52
13.79
1.1
1.1
u/ml
0.5
4.0
—
10
30
(3010421) pH of Blood
84
342
2.53
13.62
7.3
4.1
ph
7.4
7.4
0.09
77
277
(3032080) INR in Blood by Coagulation assay
695
5389
1.48
13.55
11.0
10.7
inr
1.2
1.3
5.39
268
1447
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
42
115
3.72
13.49
1.1
1.2
u/ml
0.6
0.9
0.34
19
49
(3048689) Calprotectin [Mass/mass] in Stool
208
1210
1.81
13.32
2.8
2.2
ug/g
170.5
130.6
0.74
161
951
(3010726) Horse dander IgE Ab [Units/volume] in Serum
37
94
4.00
13.19
1.1
1.1
u/ml
0.5
2.9
—
7
22
(3007164) IgA [Mass/volume] in Serum or Plasma
310
2041
1.63
12.62
1.7
1.5
g/l
2.3
2.5
0.80
228
1174
(3037692) Legionella sp identified in Specimen by Organism specific culture
19
28
6.85
12.30
1.5
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
30
69
4.40
12.17
1.0
1.1
u/ml
1.7
4.3
0.42
11
26
(3022145) Colonoscopy Study observation
207
1237
1.76
12.08
1.4
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
16
6
26.88
12.05
1.4
1.0
—
—
—
0
0
(44813793)
25
50
5.06
11.95
1.1
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
62
233
2.72
11.83
1.3
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
130
674
2.00
11.80
7.0
5.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
36
98
3.73
11.68
1.8
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
71
289
2.52
11.56
1.4
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
381
2682
1.54
11.55
3.7
2.9
mosm/kgh2o
522.9
557.8
2.52
338
2285
(3036481) Cortisol [Moles/volume] in Serum or Plasma
175
1008
1.82
11.55
2.3
2.2
nmol/l
366.2
379.6
0.38
166
910
(3003396) Base excess in Arterial blood by calculation
225
1400
1.70
11.34
5.7
7.1
mmol/l
1.5
0.8
1.87
179
1074
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
494
3682
1.47
11.33
4.1
3.3
u/l
35.3
36.4
0.09
461
3484
(46235355) HIV 1 and 2 tests - Meaningful Use set
219
1376
1.68
10.62
1.9
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
221
1394
1.67
10.56
5.8
7.1
kpa
5.2
5.0
3.21
207
1331
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
32
87
3.73
10.43
1.7
2.5
e6/l
773.3
572.8
0.69
25
72
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
10
11.06
10.16
1.4
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
219
1393
1.65
10.12
5.8
7.1
kpa
10.7
12.3
6.70
205
1332
(3047007) Chlamydophila sp Ab [Presence] in Serum
37
114
3.29
10.01
1.2
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
788
6497
1.38
9.96
6.7
6.2
umol/l
11.0
13.4
4.13
744
6140
(3026389) Candida sp identified in Specimen by Organism specific culture
38
120
3.21
9.89
1.3
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
48
175
2.79
9.74
1.2
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
292
2007
1.54
9.73
3.4
3.8
mmol/l
0.8
0.8
0.71
271
1865
(3030467) Casts [#/volume] in Urine by Automated count
480
3646
1.43
9.72
4.5
3.4
e6/l
0.5
0.5
0.03
402
2809
(21494814) CD8 cells/100 lymphocytes in Specimen
19
36
5.32
9.64
1.6
2.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
32
92
3.52
9.63
1.7
2.2
e6/l
880.1
656.6
—
10
33
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
38
123
3.13
9.51
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
848
9856
0.73
9.44
33.3
20.5
g/l
330.4
332.0
5.75
842
9736
(3013826) Glucose [Moles/volume] in Serum or Plasma
880
7433
1.37
9.36
6.0
4.8
mmol/l
6.7
6.8
0.70
836
6974
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
17
30
5.71
9.28
1.6
2.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
27
71
3.85
9.24
1.3
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
624
5020
1.38
8.88
5.8
3.8
ng/l
40.0
61.4
1.35
489
3744
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
79
379
2.13
8.87
1.9
1.5
titre
61.4
165.3
—
7
19
(3018418) pH of Serum or Plasma
485
3745
1.41
8.82
4.7
4.0
ph
7.4
7.4
0.25
149
703
(3013707) Erythrocyte sedimentation rate by Westergren method
1016
8833
1.35
8.69
6.1
3.9
mm/h
15.6
13.6
3.55
954
8052
(36304419) Bacteria [Presence] in Urine
459
3520
1.41
8.65
4.5
3.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
29
84
3.49
8.65
1.8
2.5
e9/l
0.3
0.2
0.39
24
72
(3003888) Timothy IgE Ab [Units/volume] in Serum
33
106
3.15
8.39
1.0
1.1
u/ml
6.4
7.2
0.05
15
56
(3002582) Erythrocytes [#/volume] in Urine
512
4020
1.39
8.36
4.5
3.5
e6/l
249.2
83.2
0.34
435
3135
(44790048)
38
133
2.90
8.35
1.6
1.8
—
—
—
0
0
(44806118)
38
133
2.90
8.35
1.6
1.8
—
—
—
0
0
(44790047)
38
133
2.90
8.35
1.6
1.8
—
—
—
0
0
(44790049)
38
133
2.90
8.35
1.6
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
246
1684
1.54
8.29
1.3
1.2
iu/ml
33.7
34.7
0.05
78
513
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
86
439
2.01
8.21
1.9
2.0
u/l
39.4
38.5
0.13
74
372
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
257
1795
1.51
7.86
3.1
2.5
%
20.3
22.5
1.60
220
1545
(3025018) Bordetella pertussis Ab [Titer] in Serum
21
52
4.07
7.80
1.4
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
192
1260
1.59
7.78
6.2
7.5
%
95.0
95.5
0.69
183
1216
(3025941) Bacteria identified in Stool by Culture
105
590
1.83
7.54
1.4
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
19
45
4.26
7.48
1.9
3.3
e6/l
695.0
382.1
1.01
14
24
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
762
6439
1.32
7.47
8.2
6.9
mmol/l
1.2
1.2
1.00
591
5388
(3019977) pH of Arterial blood
22
59
3.76
7.36
2.1
3.1
ph
7.4
7.4
0.72
12
16
(3010813) Leukocytes [#/volume] in Blood
1218
13229
0.74
7.32
37.6
22.8
e9/l
7.4
6.8
11.78
1194
12740
(3000963) Hemoglobin [Mass/volume] in Blood
1218
13228
0.74
7.30
37.7
22.9
g/l
132.4
133.2
0.99
1201
12939
(3026361) Erythrocytes [#/volume] in Blood
1218
13226
0.74
7.28
37.4
22.7
e12/l
4.4
4.4
0.20
1195
12738
(3035941) MCH [Entitic mass]
1218
13225
0.74
7.26
37.3
22.6
pg
30.3
30.4
1.47
1200
12933
(3024731) MCV [Entitic volume]
1218
13224
0.74
7.25
37.3
22.7
fl
91.6
91.4
0.73
1201
12933
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
503
4013
1.35
7.25
4.1
3.1
ng/l
2089.4
1983.7
0.11
431
3454
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
12
19
6.35
7.24
1.1
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
12
19
6.35
7.24
1.1
1.4
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
12
19
6.35
7.24
1.1
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1218
13223
0.74
7.23
37.5
22.7
e9/l
251.9
241.5
5.85
1195
12777
(3022948) Iron [Moles/volume] in Serum or Plasma
286
2078
1.45
7.14
2.9
2.5
umol/l
12.3
12.5
0.22
263
1904
(3008401) Mugwort IgE Ab [Units/volume] in Serum
31
106
2.96
7.13
1.0
1.1
u/ml
0.4
2.5
0.86
12
52
(3004789) Transferrin [Mass/volume] in Serum or Plasma
266
1907
1.46
7.12
2.9
2.5
g/l
2.3
2.3
1.32
245
1745
(3000570) Elastase.pancreatic [Mass/mass] in Stool
70
351
2.03
7.06
1.6
1.4
ug/g
295.5
268.6
0.50
44
200
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
307
2281
1.42
6.77
1.3
1.3
u/ml
0.9
1.7
1.76
75
582
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
21
58
3.65
6.75
1.3
1.1
iu/ml
6.3
8.9
—
5
14
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
136
855
1.64
6.58
2.0
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
389
3028
1.36
6.47
9.1
6.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
73
385
1.93
6.41
3.8
3.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
36
142
2.57
6.37
12.5
7.9
mmol/l
7.1
7.2
0.10
31
120
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
105
622
1.73
6.35
6.5
9.5
mmol/l
24.6
24.1
0.89
98
579
(3018095) Leukocytes [#/volume] in Urine
559
4607
1.31
6.28
4.9
3.9
e6/l
94.1
128.8
0.52
457
3355
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1075
11786
0.77
6.17
5.3
5.0
mmol/l
2.6
2.6
1.70
949
10679
(3041096) Erythrocytes [Presence] in Urine by Automated
394
3095
1.35
6.15
4.6
3.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
21
62
3.42
6.14
1.1
1.1
u/ml
0.2
0.2
—
7
17
(3024561) Albumin [Mass/volume] in Serum or Plasma
656
5546
1.29
6.03
5.6
4.9
g/l
34.2
34.9
2.15
621
5126
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
171
1159
1.53
6.01
2.4
2.3
g/l
0.2
0.2
0.09
155
1073
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
10
16
6.28
5.95
1.4
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
124
782
1.63
5.95
2.1
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
523
4306
1.30
5.84
3.0
3.4
mmol/l
2.3
2.3
0.44
466
3705
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
726
6236
1.28
5.83
3.2
2.6
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
35
143
2.48
5.79
1.2
1.0
—
3.1
—
0
5
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
96
571
1.72
5.75
2.1
1.9
ug/l
1.8
3.4
0.72
88
501
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
224
1622
1.44
5.66
1.3
1.2
u/ml
23.9
13.8
0.71
90
591
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
683
5838
1.28
5.66
7.8
6.3
mmol/l
1.2
1.2
0.48
620
5250
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
205
1463
1.45
5.60
1.6
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
18
52
3.49
5.45
2.3
2.9
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
581
4885
1.28
5.45
2.7
2.2
nmol/l
78.1
78.1
0.02
524
4264
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
14
34
4.14
5.36
1.3
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
0
+∞
5.21
1.8
0.0
umol/l
43.2
—
—
5
0
(3003181) Sodium [Moles/volume] in Urine
47
230
2.07
5.14
1.6
1.5
mmol/l
58.9
62.2
0.19
35
186
(3029937) Albumin [Presence] in Urine by Test strip
399
3218
1.31
5.09
4.9
4.3
estimate
0.0
0.0
0.04
172
1002
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
8
6
13.38
5.08
1.5
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
65
3.10
5.07
1.6
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
65
3.10
5.07
1.6
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
65
3.10
5.07
1.6
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
65
3.10
5.07
1.6
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
120
782
1.57
5.06
6.7
6.6
mmol/l
25.2
24.2
2.79
114
731
(3009261) Glucose [Presence] in Urine by Test strip
692
5985
1.26
5.04
4.5
3.9
estimate
0.0
0.0
0.00
172
1038
(3035350) Ketones [Presence] in Urine by Test strip
683
5899
1.26
5.03
4.4
3.9
estimate
0.0
0.0
0.00
181
1060
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1057
11496
0.80
4.94
4.8
4.5
mmol/l
4.5
4.5
0.56
937
10496
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
26
100
2.62
4.90
1.5
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1045
11371
0.80
4.86
4.8
4.5
mmol/l
1.4
1.4
1.04
924
10275
(3018677) aPTT in Platelet poor plasma by Coagulation assay
264
2021
1.36
4.80
2.8
2.5
s
30.9
30.0
1.57
254
1959
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
11
24
4.60
4.78
1.2
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
682
5915
1.25
4.78
5.9
5.2
estimate
0.0
0.0
0.38
185
1074
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
32
138
2.34
4.76
1.7
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1070
11593
0.80
4.67
5.2
4.7
mmol/l
6.2
6.0
2.51
947
10341
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
30
127
2.39
4.66
1.8
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
149
1038
1.48
4.63
1.6
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
12
29
4.16
4.62
1.4
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
164
1168
1.45
4.55
6.5
7.8
g/l
121.3
119.4
0.64
159
1127
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1185
12678
0.80
4.49
14.6
10.5
u/l
25.5
25.6
0.08
1146
12125
(3028433) Virus identified in Specimen by Culture
13
35
3.73
4.36
1.5
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
462
3873
1.26
4.27
2.6
2.2
u/l
167.7
231.6
1.39
422
3617
(3020779) Urea [Moles/volume] in Serum or Plasma
167
1212
1.42
4.19
7.4
7.5
mmol/l
10.3
10.9
0.43
158
1158
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
41
3.43
4.18
1.2
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
25
103
2.45
4.14
1.5
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
25
103
2.45
4.14
1.5
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
25
103
2.45
4.14
1.5
1.5
—
—
—
0
0
(3013512) EKG study
458
3852
1.26
4.09
5.0
4.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
63
2.88
4.06
1.2
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
528
4528
1.24
3.94
4.9
4.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
163
1196
1.40
3.86
1.6
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
42
221
1.92
3.84
1.7
2.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
231
1799
1.33
3.75
6.8
6.0
mmol/l
1.1
1.1
1.00
216
1657
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1019
10991
0.83
3.72
4.2
4.0
mmol/l
1.3
1.3
1.65
898
9863
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
347
2856
1.27
3.70
1.9
1.7
pmol/l
499.1
20703548.5
1.90
276
2304
(3026493) Urate [Moles/volume] in Serum or Plasma
388
3241
1.25
3.64
2.8
2.9
umol/l
8011.1
7520.9
0.06
328
2752
(3028707) Methadone [Presence] in Urine by Screen method
21
85
2.49
3.63
2.3
1.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
55
321
1.74
3.63
1.7
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
158
1167
1.39
3.61
7.1
6.8
mmol/l
1.4
1.4
0.29
144
1117
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
51
2.96
3.57
1.7
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
51
2.96
3.57
1.7
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
15
51
2.96
3.57
1.8
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1161
12337
0.83
3.46
24.4
14.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
28
132
2.14
3.46
5.8
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1033
9543
1.20
3.42
10.1
7.3
u/l
80.1
83.3
1.57
990
8881
(3000330) Specific gravity of Urine by Test strip
105
731
1.46
3.34
4.1
3.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
46
263
1.77
3.29
1.5
1.4
iu/l
34.4
28.4
0.48
40
222
(3002523) Influenza virus A Ag [Presence] in Specimen
28
135
2.09
3.28
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
83
553
1.53
3.27
2.6
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
349
4136
0.80
3.26
4.3
4.6
%
20.6
22.2
1.40
181
2124
(3023103) Potassium [Moles/volume] in Serum or Plasma
1192
12611
0.83
3.26
29.3
18.4
mmol/l
4.0
4.0
0.25
1169
12207
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
156
1172
1.36
3.23
3.2
3.2
ng/l
211.5
276.1
1.02
147
1067
(3019550) Sodium [Moles/volume] in Serum or Plasma
1191
12582
0.83
3.10
29.2
18.3
mmol/l
139.2
139.6
6.35
1168
12194
(21494755) Public health laboratory ask at order entry panel
39
673
0.57
3.10
1.4
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
26
125
2.10
3.08
1.2
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
52
314
1.68
3.08
2.6
2.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
29
3.46
3.04
1.0
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
409
3500
1.22
3.02
2.5
2.2
mg/l
3.2
3.0
0.86
357
2916
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
182
1415
1.32
3.01
2.7
3.2
umol/l
6.3
9.7
1.84
155
1236
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
143
1073
1.36
3.00
1.7
1.8
%
1.5
1.5
0.00
123
906
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
197
1552
1.30
2.96
3.9
4.3
u/l
242.4
261.3
0.97
177
1456
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
69
452
1.55
2.96
2.5
2.2
ug/l
218.4
571.8
1.78
64
423
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
17
69
2.48
2.96
1.9
1.6
u/l
6.5
8.5
—
10
40
(3047181) Lactate [Moles/volume] in Blood
57
357
1.62
2.95
4.7
6.8
mmol/l
1.3
1.3
0.43
51
314
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
76
510
1.51
2.92
2.3
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
19
82
2.33
2.91
3.7
2.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
50
304
1.66
2.91
1.2
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
27
135
2.02
2.91
1.1
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
531
4674
1.19
2.90
2.3
2.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
902
8304
1.18
2.90
6.2
4.7
e6/l
192.3
1961.7
1.79
18
142
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
304
2533
1.24
2.89
5.2
3.8
ng/l
136.5
451.3
3.10
245
2133
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
43
708
0.60
2.88
1.7
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
210
1676
1.29
2.87
2.9
2.7
%
1.7
1.7
0.03
179
1471
(3023183) Ammonium ion [Moles/volume] in Plasma
48
291
1.67
2.83
2.4
3.2
umol/l
38.4
34.4
0.45
39
238
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
52
322
1.63
2.83
1.7
1.6
iu/ml
0.0
0.1
—
10
68
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
25
477
0.52
2.81
1.5
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
31
165
1.89
2.81
4.2
4.2
umol/l
366.9
351.5
0.24
26
145
(3002032) Base excess in Venous blood by calculation
170
1324
1.31
2.79
6.5
4.5
mmol/l
2.1
1.6
0.70
143
1038
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
30
159
1.90
2.76
1.2
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
6
8.35
2.75
2.2
6.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
98
701
1.42
2.75
7.8
5.3
mmol/l
24.3
23.7
1.12
92
632
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
100
718
1.42
2.75
2.6
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
75
510
1.49
2.73
7.5
4.1
u/ml
0.4
0.4
0.23
50
298
(3037467) Urinalysis macro (dipstick) panel - Urine
916
8469
1.17
2.72
5.8
4.4
—
—
—
0
0
(3020891) Body temperature
76
519
1.48
2.71
5.0
4.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
24
3.76
2.67
1.8
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
453
5139
0.84
2.61
5.4
5.3
ug/l
2.6
4.3
1.35
397
4533
(3001122) Ferritin [Mass/volume] in Serum or Plasma
564
5029
1.18
2.61
3.6
2.8
ug/l
136.0
148.8
0.35
508
4543
(3016330) Potassium [Moles/time] in 24 hour Urine
5
7
7.16
2.55
1.4
1.1
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
5
7
7.16
2.55
2.4
5.4
mg/l
24.2
19.5
—
5
7
(3014576) Chloride [Moles/volume] in Serum or Plasma
200
1612
1.27
2.54
8.7
6.7
mmol/l
104.1
104.6
0.84
195
1571
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
33
3.04
2.52
1.6
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1043
11060
0.86
2.49
7.2
6.0
mmol/mol
41.8
40.5
3.76
945
10074
(3017732) Neutrophils [#/volume] in Blood
102
750
1.38
2.47
2.8
2.9
e9/l
4.5
3.9
1.21
70
552
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
36
211
1.72
2.43
4.6
3.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
125
1621
0.75
2.43
9.2
8.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
39
234
1.68
2.43
2.4
4.4
%
1.5
1.6
0.03
28
180
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
49
312
1.59
2.42
2.7
2.3
ug/min
102.5
78.5
0.23
37
187
(3039162) Centromere protein B Ab [Units/volume] in Serum
26
138
1.90
2.41
1.7
1.2
—
50.7
—
0
5
(3026008) Bacteria identified in Urine by Culture
459
4049
1.18
2.39
4.5
3.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
118
1.96
2.35
1.3
1.3
nmol/l
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
943
8800
1.15
2.33
4.2
3.8
pmol/l
14.9
14.9
0.06
858
7834
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
789
7270
1.15
2.32
3.9
3.2
u/l
59.2
53.3
0.79
730
6693
(3032057) Clostridioides difficile [Presence] in Stool
9
28
3.22
2.30
2.0
1.9
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
22
112
1.98
2.30
2.1
1.4
u/l
12.7
14.6
0.58
22
106
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
155
1.82
2.30
4.3
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
18
85
2.13
2.29
1.2
1.1
titre
308.0
171.8
—
5
17
(40768443) Skin Pathology biopsy report
71
497
1.45
2.28
1.2
1.2
—
—
—
0
0
(3000991) Gas panel - Venous blood
148
1166
1.29
2.27
9.4
8.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
13
4.63
2.27
2.3
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
22
113
1.96
2.25
2.0
2.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
89
651
1.39
2.25
7.0
10.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
10
36
2.79
2.20
2.2
2.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
24
3.34
2.18
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
143
1132
1.29
2.13
6.8
4.1
kpa
4.5
4.6
0.13
138
1093
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
25
3.21
2.09
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
64
448
1.44
2.08
1.3
1.2
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
10
5.01
2.07
1.0
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
34
208
1.65
2.01
1.7
1.2
u/ml
104.6
50.3
—
5
17
(3051611) Lipemic interference index of Serum or Plasma
24
133
1.82
1.99
3.4
3.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
44
288
1.54
1.98
1.3
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
31
187
1.67
1.94
3.7
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
11
4.55
1.94
21.8
7.7
mmol/l
5.0
5.7
—
5
11
(44816559) Phosphatidylethanol [Mass/volume] in Blood
29
172
1.70
1.93
1.4
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
322
2807
1.18
1.92
2.0
1.8
nmol/l
1066.8
1167.8
1.24
230
2070
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
95
723
1.33
1.91
2.4
2.5
au/ml
47.1
14.7
—
5
25
(3020961) Endomysium IgA Ab [Titer] in Serum
67
482
1.41
1.90
1.1
1.1
titre
—
135.1
—
0
11
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
28
2.86
1.86
1.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
23
129
1.79
1.85
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1011
10642
0.88
1.85
26.5
16.9
%
38.7
38.7
0.02
616
7021
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
46
2.40
1.85
1.5
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
51
352
1.46
1.82
4.9
3.9
g/l
3.9
3.5
1.02
46
339
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
31
191
1.63
1.81
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
18
94
1.92
1.80
1.2
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
81
608
1.35
1.80
1.2
1.2
iu/ml
109.0
153.2
0.72
20
220
(3045414) Leukocytes [Presence] in Urine
75
559
1.36
1.75
2.2
1.9
—
—
—
0
0
(4024509)
21
117
1.80
1.74
1.4
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
35
225
1.57
1.74
1.5
1.5
u/l
8.0
9.0
0.22
28
175
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
8
30
2.67
1.72
1.4
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
24
2.92
1.72
1.1
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
13
61
2.14
1.71
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
49
341
1.45
1.69
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
259
2972
0.85
1.67
3.2
3.2
ug/l
0.8
0.9
0.60
182
2051
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
49
2.25
1.63
1.5
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
36
237
1.53
1.63
1.4
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
86
663
1.31
1.62
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
31
198
1.58
1.60
4.1
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
48
337
1.44
1.60
1.1
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
258
2247
1.17
1.57
3.7
2.9
e6/l
1.3
1.2
0.15
158
1328
(3022493) Free Hemoglobin [Mass/volume] in Plasma
12
57
2.11
1.55
3.1
3.3
mg/l
21777.0
77.6
—
7
41
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
15
3.34
1.52
2.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
31
201
1.55
1.51
3.9
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
38
258
1.48
1.51
1.3
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
123
1.72
1.51
1.4
1.4
pmol/l
424.5
358.2
0.15
15
99
(3028300) Cannabinoids [Presence] in Urine
31
202
1.54
1.48
4.0
1.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
47
336
1.41
1.44
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
64
482
1.34
1.44
1.0
1.0
—
—
—
0
0
(4198724)
6
22
2.73
1.43
2.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
148
1238
1.21
1.43
3.1
2.7
e9/l
67.6
66.3
0.20
106
958
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
44
312
1.42
1.42
2.3
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
88
1.83
1.41
1.1
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
19
313
0.60
1.40
1.1
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
46
2.18
1.40
2.7
2.6
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
17
2.95
1.36
1.2
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
14
75
1.87
1.34
3.6
1.4
—
76.4
—
0
5
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
32
216
1.49
1.33
1.5
1.5
u/ml
135.1
107.6
—
8
40
(3027944) Amphetamines [Presence] in Urine
30
200
1.51
1.32
4.3
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
41
0.00
1.31
0.0
1.4
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
24
2.50
1.30
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
25
161
1.56
1.29
2.7
2.1
u/l
10286.8
3531.7
—
5
63
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
39
277
1.42
1.27
1.6
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
137
1154
1.20
1.26
1.8
2.8
g/l
66.4
65.9
0.29
121
1035
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
147
1247
1.19
1.25
3.1
2.4
ug/l
4.7
7.0
1.60
121
1070
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
79
627
1.27
1.25
3.5
3.3
pmol/l
4.6
4.4
0.71
74
538
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
243
2150
1.15
1.23
4.0
3.1
e6/l
3.2
2.0
1.34
139
1234
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
11
56
1.97
1.22
1.2
1.3
%
—
72.2
—
0
6
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
19
2.64
1.21
1.0
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
38
272
1.41
1.20
1.7
1.2
u/ml
2.2
2.8
—
5
21
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
101
1.69
1.19
1.6
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
35
247
1.43
1.19
1.5
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
26
2.31
1.18
1.0
1.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
25
165
1.52
1.17
1.3
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
134
1572
0.84
1.16
4.4
4.6
%
34.0
33.0
0.46
95
1028
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
33
0.00
1.16
0.0
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
345
3137
1.12
1.16
5.2
4.4
%
90.2
84.8
3.59
333
3055
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
20
2.50
1.15
1.4
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
20
2.50
1.15
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
20
2.50
1.15
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
20
2.50
1.15
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
20
2.50
1.15
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
13
72
1.81
1.15
1.6
2.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
14
80
1.76
1.13
1.4
1.4
promille
2.0
0.9
—
9
59
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
38
276
1.38
1.12
1.7
1.2
u/ml
5.2
9.2
—
7
41
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
36
259
1.40
1.12
1.8
1.9
e6/l
2.9
36.5
0.87
28
209
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
85
694
1.24
1.09
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
132
1126
1.19
1.08
2.8
2.4
u/l
37.2
37.9
0.04
121
944
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
32
2.19
1.08
2.3
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
278
0.64
1.06
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
345
3155
1.12
1.05
1.7
1.6
nmol/l
21.2
20.5
0.12
301
2648
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
67
1.80
1.04
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
276
0.65
1.03
1.6
1.4
—
—
—
0
0
(4133840)
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
16
98
1.64
1.03
1.4
1.4
—
33.6
—
0
7
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
31
221
1.41
1.03
1.3
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
34
2.06
1.03
3.7
3.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
47
1.92
1.02
1.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
68
1.77
1.00
1.8
2.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
35
2.00
1.00
1.3
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
35
2.00
1.00
1.3
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
115
1.57
0.99
1.3
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
18
115
1.57
0.99
1.6
2.0
—
1.1
—
0
6
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
13
76
1.72
0.99
1.2
1.3
—
241.3
—
0
8
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
118
1007
1.18
0.98
4.3
4.0
ng/l
91.6
90.3
0.05
99
863
(3022621) pH of Urine by Test strip
106
896
1.19
0.98
3.7
3.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
22
148
1.49
0.98
1.3
1.2
u/ml
1.8
2.1
—
10
42
(3002256) Pathology report gross observation
184
1627
1.15
0.97
1.5
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
31
0.00
0.96
0.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
221
1983
1.13
0.94
20.2
29.8
inr
1.4
1.5
0.23
41
265
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
37
1.90
0.94
2.4
1.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
37
1.90
0.94
2.4
1.9
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
27
2.23
0.93
1.2
1.7
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
25
175
1.43
0.93
2.4
2.3
u/ml
497.8
28.9
0.50
25
169
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
28
2.15
0.91
1.3
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
63
1.75
0.90
1.2
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
29
2.07
0.89
1.0
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
42
1.91
0.88
1.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
119
1.52
0.88
1.5
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
29
212
1.37
0.86
1.2
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
416
3886
1.09
0.84
3.2
3.2
mmol/l
7.4
7.3
0.05
331
3208
(3020650) Glucose [Presence] in Urine
6
31
1.94
0.84
1.0
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
31
1.94
0.84
1.3
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
22
154
1.43
0.83
3.0
5.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
113
0.53
0.83
2.2
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
32
1.88
0.81
1.3
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
270
2475
1.11
0.81
3.0
3.1
mmol/l
2.5
2.5
1.02
236
2170
(3006462) Nitrate [Presence] in Urine
10
58
1.73
0.79
3.3
3.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
33
1.82
0.79
1.3
1.1
—
—
—
0
0
(4034850)
29
384
0.75
0.79
8.4
11.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1073
11029
0.93
0.78
23.8
14.6
ml/min/173m2
77.4
75.0
2.93
956
9102
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
26
0.00
0.78
0.0
1.2
—
1.5
—
0
19
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
124
0.56
0.77
1.4
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
28
208
1.35
0.77
1.4
1.5
u/ml
345.2
240.1
0.75
18
116
(3034426) Prothrombin time (PT)
6
34
1.77
0.76
1.5
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
10
59
1.70
0.75
1.3
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
53
1.70
0.75
1.3
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
287
3097
0.91
0.74
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
23
167
1.38
0.73
1.7
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
23
167
1.38
0.73
1.7
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
23
167
1.38
0.73
1.7
1.3
—
—
—
0
0
(4035726)
122
1074
1.15
0.73
1.5
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
56
1.61
0.72
1.1
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
69
581
1.19
0.72
1.8
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
68
1.62
0.71
1.0
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
23
168
1.37
0.71
1.7
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
23
168
1.37
0.71
1.7
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
23
168
1.37
0.71
1.7
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
26
194
1.34
0.71
2.7
2.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
57
1.58
0.71
1.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
397
3731
1.08
0.71
3.2
3.2
mg/l
345.0
306.7
0.07
268
2369
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
565
5384
1.07
0.70
2.1
2.1
pmol/l
94.5
93.0
0.32
310
2836
(4306422)
19
135
1.41
0.69
1.3
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
227
0.70
0.68
1.4
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
37
294
1.26
0.66
10.5
4.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
15
103
1.46
0.65
1.1
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
33
260
1.27
0.64
1.8
1.8
mmol/l
4.6
3.8
0.31
28
246
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
5
29
1.73
0.64
1.0
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
386
3641
1.08
0.63
3.4
3.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
164
1.35
0.62
1.0
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
71
1.55
0.62
1.8
2.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
104
0.58
0.62
2.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
105
0.57
0.61
2.2
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
105
0.57
0.61
2.2
1.4
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
30
1.67
0.61
1.0
2.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
88
1.48
0.60
3.3
3.1
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
34.7
—
0
16
(40765089) Chromosome analysis panel - Blood by G-banded
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
80
1.50
0.59
1.0
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
22
0.00
0.59
0.0
1.2
—
1.6
—
0
17
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
53
1.51
0.58
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
53
1.51
0.58
1.1
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
140
1.36
0.58
2.8
4.1
%
64.2
54.4
—
10
87
(3036489) Thrombin time
54
456
1.19
0.58
3.0
3.1
s
21.2
21.6
0.19
49
423
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
33
265
1.25
0.56
3.0
3.0
u/ml
288.9
1449.8
0.63
27
249
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
22
167
1.32
0.56
1.0
1.1
iu/ml
212.9
34.1
—
9
32
(3004588) Protein electrophoresis panel - Serum or Plasma
107
955
1.13
0.56
1.9
2.5
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
86
0.58
0.56
1.8
2.1
ug/l
1.5
2.0
—
5
75
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
86
0.58
0.56
2.2
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
5
87
0.57
0.56
1.2
2.0
ug/l
5.5
3.2
—
5
77
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
88
0.57
0.56
2.2
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
88
0.57
0.56
2.2
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
88
0.57
0.56
2.2
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
71
616
1.16
0.56
2.2
1.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
65
1.54
0.55
1.1
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
13
90
1.45
0.55
1.3
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
8
124
0.64
0.54
1.5
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
57
487
1.18
0.54
3.8
3.7
g/l
0.2
0.3
0.38
22
206
(3044007) Cell count panel - Peritoneal fluid
6
38
1.58
0.54
1.5
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
78
684
1.15
0.54
2.3
1.9
—
—
—
0
0
(4211845)
10
66
1.52
0.52
3.3
3.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
143
1.33
0.52
1.2
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
107
961
1.12
0.52
3.1
2.9
ml/min/173m2
54.6
62.7
1.39
54
414
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
83
1.45
0.51
1.5
1.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
9
64
1.41
0.51
2.7
3.6
nmol/l
86.2
90.7
—
9
64
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
109
1.38
0.51
2.3
2.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
15
109
1.38
0.51
1.2
1.1
%
97.1
98.6
0.09
15
102
(3027273) Bicarbonate [Moles/volume] in Venous blood
77
679
1.14
0.50
4.4
3.2
mmol/l
25.5
24.8
0.88
77
660
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
84
1.43
0.49
1.0
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
414
3953
1.06
0.49
4.2
3.9
mg/mmol
10.8
14.2
0.30
267
2505
(40768795) Lymph node Pathology biopsy report
16
119
1.35
0.48
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
40
336
1.19
0.47
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
57
494
1.16
0.47
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
39
327
1.20
0.47
1.3
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
22
173
1.27
0.46
1.8
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
49
1.43
0.46
1.6
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
85
0.59
0.45
2.2
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
165
1.28
0.45
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
24
192
1.25
0.45
1.3
1.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
141
0.71
0.45
2.0
2.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
51
441
1.16
0.44
1.1
1.0
—
1.9
—
0
7
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
69
1.45
0.44
1.3
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
69
1.45
0.44
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
79
706
1.12
0.44
1.5
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
47
405
1.16
0.43
5.4
4.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
31
1.61
0.43
1.4
1.4
ug/l
7.8
10.2
—
5
31
(4027681)
8
56
1.43
0.42
1.9
1.2
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
32
1.56
0.42
1.2
1.6
pmol/l
15.0
15.5
—
5
22
(3009015) Lactate [Moles/volume] in Synovial fluid
0
16
0.00
0.41
0.0
1.3
—
7.0
—
0
11
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
17
0.00
0.40
0.0
4.8
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
88
1.37
0.40
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
104
0.67
0.39
2.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
84
760
1.11
0.39
2.7
2.8
e6/l
0.2
0.4
1.31
84
741
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
19
0.00
0.39
0.0
2.6
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
19
0.00
0.39
0.0
2.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
22
178
1.24
0.38
1.8
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
17
133
1.28
0.38
2.1
2.2
u/field
1.6
2.5
—
8
41
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
66
1.37
0.38
2.0
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
67
1.34
0.38
2.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
89
1.35
0.38
1.3
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
5
37
1.35
0.37
1.2
1.1
u/ml
—
17.1
—
0
7
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
10
72
1.39
0.37
1.2
1.1
mg/l
70.8
34.6
—
5
62
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
451
1.13
0.35
1.8
3.5
mg/l
52.3
67.7
0.44
36
369
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
51
451
1.13
0.35
1.8
3.6
mg/l
42.1
43.3
0.05
36
370
(21494434) Karyotype in Bone marrow
11
145
0.76
0.34
1.5
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
37
320
1.16
0.34
3.3
3.1
nmol/l
0.8
0.8
0.13
31
244
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
45
1.33
0.33
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
118
1266
0.93
0.32
1.5
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
38
332
1.15
0.32
1.7
3.8
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
949
9647
0.96
0.32
31.3
19.1
%
14.0
13.8
3.43
925
9396
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
53
1.32
0.30
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
249
1.17
0.30
2.7
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
138
1.23
0.30
2.3
2.5
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
17
138
1.23
0.30
1.6
1.5
%
64.0
65.8
0.06
11
92
(3037756) Immunofixation for Serum or Plasma
36
315
1.15
0.30
1.1
1.6
—
—
—
0
0
(4268621)
13
102
1.28
0.30
2.5
2.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
93
1.29
0.30
1.8
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
89
824
1.08
0.29
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
76
1.32
0.28
3.8
3.5
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
8
63
1.27
0.27
2.5
1.5
u/l
5.1
6.2
—
8
52
(3000475) Leukocytes [#/volume] in Synovial fluid
33
290
1.14
0.27
1.3
1.7
e6/l
10934.1
14413.4
0.40
21
213
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
40
357
1.12
0.26
2.1
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
73
0.68
0.26
8.6
7.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
38
425
0.89
0.25
1.8
2.4
g/l
34.5
37.3
1.52
31
354
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
508
0.90
0.25
1.7
2.5
g/l
3.6
3.1
1.94
35
391
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
29
254
1.14
0.25
1.6
1.7
iu/l
7.3
4.8
—
10
79
(3019225) pH of Specimen
137
1298
1.06
0.25
4.2
4.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
114
1.23
0.25
1.1
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
21
244
0.86
0.24
1.2
1.8
nmol/l
1.1
0.8
0.46
16
204
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
84
0.71
0.24
1.3
4.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
115
1.22
0.23
2.5
2.5
—
—
—
0
0
(3024471) HLA-A [Type]
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
16
134
1.20
0.22
2.5
2.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
41
1.22
0.22
1.0
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
302
3111
0.96
0.22
3.1
2.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
107
1.22
0.21
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
42
1.19
0.21
1.4
2.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
135
1.19
0.21
1.4
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
311
3021
1.04
0.21
1.7
1.6
mmol/l
1.4
1.3
1.08
224
2521
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
43
1.16
0.21
6.0
2.5
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
13
0.00
0.21
0.0
2.8
—
12.4
—
0
13
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
14
0.00
0.20
0.0
1.0
—
10.1
—
0
8
(3019150) Specific gravity of Urine by Refractometry
258
2656
0.97
0.19
4.4
4.3
kg/l
1.0
1.0
1.21
46
415
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
53
1.13
0.18
1.3
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
17
196
0.87
0.18
2.1
1.8
pmol/l
155.6
211.8
1.46
17
185
(3004616) Nuclear Ab [Presence] in Serum
14
119
1.18
0.17
1.6
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
11
91
1.21
0.17
1.4
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1185
11939
0.98
0.17
28.2
15.3
mg/l
24.4
27.2
2.46
1090
9528
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
66
0.76
0.17
1.2
2.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
34
311
1.09
0.16
7.1
3.5
mg/l
36.4
29.3
0.41
25
204
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
78
0.77
0.15
2.3
2.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
78
1.15
0.15
2.2
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
28
307
0.91
0.15
1.8
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
121
1.16
0.15
1.1
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
33
358
0.92
0.15
1.5
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
93
1.18
0.14
1.1
1.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
150
1.13
0.14
1.4
1.2
u/ml
4.2
5.2
—
10
66
(3011648) Oxygen content in Venous blood
13
112
1.16
0.14
1.1
6.9
%
12.8
11.1
0.84
13
112
(3035637) Corticotropin [Mass/volume] in Plasma
15
131
1.15
0.14
2.2
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
19
211
0.90
0.13
1.7
1.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
13
113
1.15
0.13
1.5
1.3
u/l
18.4
12.9
0.41
13
107
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
190
0.89
0.13
1.6
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
161
1.12
0.13
1.4
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
53
501
1.06
0.12
2.3
3.0
u/ml
359.6
8212.8
0.82
47
434
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
37
396
0.93
0.12
1.8
2.5
g/l
0.0
0.0
0.70
32
353
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
171
1.11
0.12
2.3
2.3
mg/l
35.3
27.5
—
6
37
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1087
10796
1.02
0.12
5.1
4.5
mu/l
1.9
2.1
0.93
988
9662
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
158
0.88
0.12
2.9
1.6
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
106
1097
0.96
0.12
1.7
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
86
1.16
0.11
1.5
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
18
163
1.11
0.10
1.8
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
26
241
1.08
0.10
1.3
1.3
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
46
483
0.95
0.09
1.9
3.5
u/ml
20.8
70.3
3.38
41
468
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
46
1.09
0.09
1.4
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
47
1.06
0.09
2.0
1.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
48
1.04
0.09
1.0
1.1
iu/ml
256.6
266.4
—
5
48
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
16
145
1.10
0.09
1.7
1.3
u/l
482.3
313.0
0.25
16
138
(3013727) Leukocytes other/100 leukocytes in Blood
6
54
1.11
0.09
1.2
5.1
%
51.7
54.4
—
6
49
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
142
1388
1.02
0.08
3.5
3.9
ug/l
6.9
25.2
1.75
122
1164
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
88
1.14
0.08
1.1
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
72
0.83
0.07
1.2
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
33
313
1.06
0.07
2.6
1.8
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
108
1.11
0.07
1.0
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
7
83
0.84
0.07
1.9
1.1
—
43.4
—
0
5
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
84
0.83
0.07
1.9
1.1
—
38.5
—
0
8
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
93
0.86
0.06
1.0
1.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
44
457
0.96
0.06
1.8
2.6
g/l
1.0
1.3
0.27
34
382
(3017446) Testosterone [Moles/volume] in Serum or Plasma
91
889
1.02
0.06
2.5
2.2
nmol/l
9.8
11.9
1.78
75
763
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
178
1.07
0.05
1.1
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
64
624
1.03
0.05
2.3
2.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
112
1101
1.02
0.05
3.6
3.5
—
—
—
0
0
(4094501)
31
298
1.04
0.04
1.1
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
36
372
0.97
0.04
1.8
2.5
g/l
0.0
0.0
0.00
31
332
(3044889) 12 lead EKG panel
850
8526
0.99
0.04
5.1
4.0
—
—
—
0
0
(4146454)
15
141
1.06
0.03
1.8
2.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
68
668
1.02
0.03
1.8
1.7
g/l
1.5
1.5
0.12
62
573
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
24
231
1.04
0.02
1.1
1.2
miu/ml
242.9
197.5
—
7
97
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
379
0.98
0.02
1.6
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
52
511
1.02
0.02
1.8
2.5
g/l
9.8
10.5
0.42
43
422
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
574
5724
1.00
0.02
5.1
4.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
288
2868
1.00
0.01
4.1
3.8
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
16
154
1.04
0.00
1.5
1.4
mmol/l
5.2
6.8
1.63
16
146
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
546
0.99
0.00
1.8
2.5
g/l
8.1
7.4
1.27
34
398
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
106
1.04
0.00
1.3
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
252
0.99
0.00
1.5
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
19
194
0.98
0.00
1.1
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
11
109
1.01
0.00
1.5
1.4
%
18.2
26.2
—
6
71
(3044640) Blood type and Crossmatch panel - Blood
403
4027
1.00
0.00
3.3
2.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
545
0.99
0.00
1.8
2.5
g/l
3.8
3.8
0.06
34
383
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
54
545
0.99
0.00
1.8
2.5
—
—
—
0
0
(4281824)
12
118
1.02
0.00
1.0
1.1
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
58.8
—
0
5
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
29.8
—
0
5
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
61
0.98
0.00
1.5
1.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
367.2
—
0
5
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
1.1
—
0
5
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
69
0.87
0.00
1.5
1.7
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
6.2
—
0
8
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
7
0.00
0.00
0.0
1.9
—
1.9
—
0
7
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
88
0.91
0.00
1.4
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
9
93
0.97
0.00
1.1
1.6
—
—
—
0
0
(3006598) pH of Arterial cord blood
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
69
0.87
0.00
1.0
1.6
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
5
54
0.93
0.00
1.4
1.7
mmol/l
5.5
10.1
—
5
42
(3029396) Erythrocyte agglutination [Presence] in Blood
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
85
0.94
0.00
1.7
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
5
56
0.89
0.00
1.0
1.0
—
1.0
—
0
5
(3016031) Almond IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
1.7
—
0
9
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint J10_SIMPLBRONCH and mortality.

Females

Parameter HR [95% CI] p-value
J10_SIMPLBRONCH 2.004 [1.78, 2.25] < 0.001
Birth year 0.993 [0.98, 1.0] 0.111

During the follow-up period (1.1.1998 — 31.12.2019), 1102 out of 3129 females with J10_SIMPLBRONCH died.

Males

Parameter HR [95% CI] p-value
J10_SIMPLBRONCH 2.066 [1.84, 2.32] < 0.001
Birth year 0.989 [0.98, 1.0] 0.018

During the follow-up period (1.1.1998 — 31.12.2019), 1687 out of 3566 males with J10_SIMPLBRONCH died.

Mortality risk

Mortality risk for people of age

years, who have J10_SIMPLBRONCH.

N-year risk Females Males
1 0.186% 0.437%
5 1.027% 2.415%
10 2.692% 5.921%
15 5.329% 11.176%
20 9.318% 18.593%

Relationships between endpoints

↥

Index endpoint: J10_SIMPLBRONCH – Simple and mucopurulent chronic bronchitis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data